Literature DB >> 10609595

Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community.

J Lorvick1, S Thompson, B R Edlin, A H Kral, A R Lifson, J K Watters.   

Abstract

SETTING: A community-based directly observed preventive therapy (DOPT) program for treatment of latent tuberculosis infection among injection drug users (IDUs) in an inner-city neighborhood.
OBJECTIVE: To test adherence to a 6-month course of DOPT using cash incentives and an easily accessible neighborhood location.
DESIGN: Street-recruited IDUs (N = 205) were screened for Mycobacterium tuberculosis (TB) infection using the Mantoux test and two controls. Subjects who had a purified protein derivative (PPD) reaction of > or =5 mm, were anergic, or had a history of a positive PPD received clinical evaluation at a community field site, provided in collaboration with the San Francisco Department of Public Health Tuberculosis Clinic. Twenty-eight subjects were considered appropriate candidates for prophylaxis with isoniazid, and 27 enrolled in the pilot study. Participants received twice-weekly DOPT at a community satellite office, with a $10 cash incentive at each visit.
RESULTS: The 6-month (26-week) regimen was completed by 24/27 (89%) participants. The median time to treatment completion was 27 weeks (range 26 to 34 weeks). The median proportion of dosing days attended in 6 months was 96%.
CONCLUSION: Community-based DOPT using cash incentives resulted in high levels of adherence and treatment completion among drug users.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609595      PMCID: PMC3456694          DOI: 10.1007/BF02351503

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  24 in total

1.  Monetary versus nonmonetary incentives for TB skin test reading among drug users.

Authors:  C K Malotte; J R Hollingshead; F Rhodes
Journal:  Am J Prev Med       Date:  1999-04       Impact factor: 5.043

2.  The use of preventive therapy for tuberculous infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1990-05-18

3.  Tuberculosis screening and compliance with return for skin test reading among active drug users.

Authors:  C K Malotte; F Rhodes; K E Mais
Journal:  Am J Public Health       Date:  1998-05       Impact factor: 9.308

4.  Directly observed therapy in an inner city hospital.

Authors:  M Smirnoff; R Goldberg; L Indyk; J J Adler
Journal:  Int J Tuberc Lung Dis       Date:  1998-02       Impact factor: 2.373

5.  A patient education program to improve adherence rates with antituberculosis drug regimens.

Authors:  D E Morisky; C K Malotte; P Choi; P Davidson; S Rigler; B Sugland; M Langer
Journal:  Health Educ Q       Date:  1990

6.  Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992.

Authors:  J K Watters
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-12

7.  Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993.

Authors:  W el-Sadr; F Medard; V Berthaud; V Barthaud
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

Review 8.  Supervised therapy in San Francisco.

Authors:  G F Schecter
Journal:  Clin Chest Med       Date:  1997-03       Impact factor: 2.878

9.  Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral.

Authors:  L Pilote; J P Tulsky; A R Zolopa; J A Hahn; G F Schecter; A R Moss
Journal:  Arch Intern Med       Date:  1996-01-22

10.  Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-04-17
View more
  14 in total

1.  Lack of awareness of hepatitis C risk among persons who received blood transfusions before 1990.

Authors:  J Buffington; R Rowel; J M Hinman; K Sharp; S Choi
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif.

Authors:  J Lorvick; A H Kral; K Seal; L Gee; B R Edlin
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

3.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

4.  Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis.

Authors:  Ricky N Bluthenthal; D Phuong Do; Brian Finch; Alexis Martinez; Brian R Edlin; Alex H Kral
Journal:  J Urban Health       Date:  2007-07-27       Impact factor: 3.671

Review 5.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 6.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

7.  Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.

Authors:  Ekaterina Moroz; Randy A Albrecht; Brandon Aden; Ann Bordwine Beeder; Jianda Yuan; Adolfo García-Sastre; Brian R Edlin; Mirella Salvatore
Journal:  Vaccine       Date:  2016-02-06       Impact factor: 3.641

Review 8.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

9.  Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing.

Authors:  David C Perlman; Patricia Friedmann; Leslie Horn; Anne Nugent; Veronika Schoeb; Jeanne Carey; Nadim Salomon; Don C Des Jarlais
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

10.  Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Authors:  Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.